Fulgent Genetics, Inc. Common Stock (FLGT)

SERVICES-MEDICAL LABORATORIES

Fulgent Genetics, Inc. Common Stock (FLGT) is listed on Nasdaq, where it has traded since September 29, 2016.

Listed On
Nasdaq
Listed Since
September 29, 2016
Employees
1,315
Market Cap
$611M

About Fulgent Genetics, Inc. Common Stock

Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in the laboratory services business and the therapeutic development business. The laboratory services business, which generates key revenue, includes technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue, and Foreign.

Institutional ownership

In 13F filings for the quarter ended June 30, 2026, 135 institutions reported holding FLGT, with 15.6 million shares worth $319.2 million in aggregate. The largest reported holder was BlackRock, with 2.3 million shares worth $46.9 million. Of the 5 largest holders listed below, 2 added shares and 3 reduced their positions during the quarter.

InstitutionSharesValueQuarter change
BlackRock2,286,669$47MReduced 17.58%
Vanguard1,111,330$23MReduced 10.8%
Acadian Asset Management1,017,913$21MReduced 17.51%
Jacobs Levy Equity Management782,116$16MAdded 119.47%
JPMorgan Chase756,558$16MAdded 64.34%

Form 13F is a quarterly report that institutional investment managers with at least $100 million in qualifying securities file with the SEC. It lists long positions as of the last day of the quarter and is due within 45 days of quarter end, so these holdings describe that date rather than today.

Frequently asked questions

What is FLGT?

Fulgent Genetics, Inc. Common Stock (FLGT) is listed on Nasdaq, where it has traded since September 29, 2016.

Who are the largest institutional holders of FLGT?

In 13F filings for the quarter ended June 30, 2026, the largest reported holders of FLGT were BlackRock, Vanguard and Acadian Asset Management.

How many institutions own FLGT?

135 institutions reported a position in FLGT for the quarter ended June 30, 2026, worth $319.2 million in total.

Did institutions buy or sell FLGT last quarter?

Of the 5 largest reported holders, 2 added shares and 3 reduced their positions during the quarter. Every reported holder and its change is on the SentiSense ownership page for FLGT.

Every reported institutional holder, plus insider and congressional trades in FLGT, on SentiSense.